GE Healthcare inks licensing deal with Israel-based DiA Imaging Analysis

This article was originally published here

DIA Imaging Analysis, GE Healthcare

GE Healthcare (NYSE:GE) has inked a multi-year, non-exclusive licensing and professional services deal with medical imaging analysis company DiA Imaging Analysis, according to a press release from the company.

Through the deal, Israel-based DiA said it intends to develop its automated imaging analysis tech to work with GE’s ultrasound devices.

“We are pleased to partner with DiA Imaging Analysis. GE Healthcare has a long history of bringing innovative solutions to our customers around the world. These tools would bring new capabilities to ultrasound at the point of care,” GE healthcare primary & affordable care GM Rob Walton said in a prepared statement.

DiA said its imaging analysis tech is designed to deliver reproducible imaging interpretation of ultrasound for point of care settings, utilizing pattern recognition and machine learning algorithm to improve monitoring of patient conditions.

“We are excited with this collaboration, and look forward to working with a market leader such as GE Healthcare.  Our advanced automated tools for point of care echo ultrasound analysis are first to market, and we are planning to soon launch additional automated imaging analysis tools as part of our vision to improve patient care,” DiA co-founder & CEO Hila Aslan said in a press release.

“To date, we are the only company that offers automated tools for handheld ultrasound devices and we are proud to partner with GE Healthcare to provide immediate information at the point of care,” DiA viz dev VP & chair Arnon Toussia-Cohen said in prepared remarks.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply